These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32623395)

  • 41. Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
    Bitto A; Giuliani D; Pallio G; Irrera N; Vandini E; Canalini F; Zaffe D; Ottani A; Minutoli L; Rinaldi M; Guarini S; Squadrito F; Altavilla D
    Inflamm Res; 2017 May; 66(5):389-398. PubMed ID: 28238167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
    Segal-Gavish H; Danino O; Barhum Y; Ben-Zur T; Shai E; Varon D; Offen D; Fischer B
    J Alzheimers Dis; 2017; 58(2):389-400. PubMed ID: 28453480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease.
    Jürgenson M; Zharkovskaja T; Noortoots A; Morozova M; Beniashvili A; Zapolski M; Zharkovsky A
    J Pharm Pharmacol; 2019 Nov; 71(11):1695-1705. PubMed ID: 31531878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
    Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
    J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD.
    Tohda C; Nakada R; Urano T; Okonogi A; Kuboyama T
    Int J Neurosci; 2011 Dec; 121(12):641-8. PubMed ID: 21770858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
    Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
    Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease.
    Girard SD; Jacquet M; Baranger K; Migliorati M; Escoffier G; Bernard A; Khrestchatisky M; Féron F; Rivera S; Roman FS; Marchetti E
    Hippocampus; 2014 Jul; 24(7):762-72. PubMed ID: 24596271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intranasal administration of Exendin-4 antagonizes Aβ31-35-induced disruption of circadian rhythm and impairment of learning and memory.
    Wang X; Wang L; Xu Y; Yu Q; Li L; Guo Y
    Aging Clin Exp Res; 2016 Dec; 28(6):1259-1266. PubMed ID: 26920423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.
    Chen Y; Zhao Y; Dai CL; Liang Z; Run X; Iqbal K; Liu F; Gong CX
    Exp Neurol; 2014 Nov; 261():610-9. PubMed ID: 24918340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Centella asiatica attenuates hippocampal mitochondrial dysfunction and improves memory and executive function in β-amyloid overexpressing mice.
    Gray NE; Zweig JA; Caruso M; Zhu JY; Wright KM; Quinn JF; Soumyanath A
    Mol Cell Neurosci; 2018 Dec; 93():1-9. PubMed ID: 30253196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
    Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer's disease.
    Bobkova NV; Garbuz DG; Nesterova I; Medvinskaya N; Samokhin A; Alexandrova I; Yashin V; Karpov V; Kukharsky MS; Ninkina NN; Smirnov AA; Nudler E; Evgen'ev M
    J Alzheimers Dis; 2014; 38(2):425-35. PubMed ID: 23985416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease.
    Rangasamy SB; Corbett GT; Roy A; Modi KK; Bennett DA; Mufson EJ; Ghosh S; Pahan K
    J Alzheimers Dis; 2015; 47(2):385-402. PubMed ID: 26401561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nasal Cavity Administration of Melanin-Concentrating Hormone Improves Memory Impairment in Memory-Impaired and Alzheimer's Disease Mouse Models.
    Oh ST; Liu QF; Jeong HJ; Lee S; Samidurai M; Jo J; Pak SC; Park HJ; Kim J; Jeon S
    Mol Neurobiol; 2019 Dec; 56(12):8076-8086. PubMed ID: 31183806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tartary buckwheat improves cognition and memory function in an in vivo amyloid-β-induced Alzheimer model.
    Choi JY; Cho EJ; Lee HS; Lee JM; Yoon YH; Lee S
    Food Chem Toxicol; 2013 Mar; 53():105-11. PubMed ID: 23219778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.
    Bhattacharya S; Maelicke A; Montag D
    J Alzheimers Dis; 2015; 46(1):123-36. PubMed ID: 25720404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term (15 mo) dietary supplementation with pomegranates from Oman attenuates cognitive and behavioral deficits in a transgenic mice model of Alzheimer's disease.
    Subash S; Braidy N; Essa MM; Zayana AB; Ragini V; Al-Adawi S; Al-Asmi A; Guillemin GJ
    Nutrition; 2015 Jan; 31(1):223-9. PubMed ID: 25441596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
    Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
    Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phloroglucinol ameliorates cognitive impairments by reducing the amyloid β peptide burden and pro-inflammatory cytokines in the hippocampus of 5XFAD mice.
    Yang EJ; Mahmood U; Kim H; Choi M; Choi Y; Lee JP; Cho JY; Hyun JW; Kim YS; Chang MJ; Kim HS
    Free Radic Biol Med; 2018 Oct; 126():221-234. PubMed ID: 30118828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.